Thus, the weakened IFNγ response to SARS-CoV-2 and elevated levels of immunosuppressive IL-10 in both COVID-19 and dengue during the early phase of illness indicates an inadequate antiviral response that could contribute to the severity of the diseases. Here, IL10 is linked to dengue disease.